19m
'Cancer vaccines are coming': Merck, Moderna clear Phase 3 hurdle as Korean biotech joins the race
The messenger RNA (mRNA) technology that became humanity's frontline defense during the COVID-19 pandemic has now crossed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results